Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Automobile body
Stable file system
Flood protection apparatus and container data center including the same
Medical device arm
Piperazinyl methyl phenyl cyclohexane compound
Method and apparatus for policy-based network access control with arbitrary network access control frameworks
  Randomly Featured Patents
Phenacyl-type esters of phenyl-substituted PGE-type compounds
Recovery of heat from flue gas
Flame retardant polypropylene resin composition
Core sample test method and apparatus
Method for manufacturing semiconductor device
Wireless telephone
Dual fuel system for combustion engines
Receiving circuit, use, and method for receiving an encoded and modulated radio signal
Inhibitors of HIV protease
Multijunction solar cell with a bypass diode having an intrinsic layer